Aug. 12 at 10:19 PM
$OPRX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.04 down -150.00% YoY
• Reported revenue of
$20.5M down -29.77% YoY
• OptimizeRx Corp is reiterating its fiscal year 2026 guidance, expecting revenue of
$95 million to
$100 million and adjusted EBITDA of
$21 million to
$25 million for the full year.
